BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 16827987)

  • 21. Value of combined 67Ga and 99Tc(m)-human immunoglobulin G whole-body scanning in malignant lymphoma.
    Küçük NO; Aras G; Soylu A; Ozcan M; Ibis E; Dinçol D
    Nucl Med Commun; 2001 Mar; 22(3):325-9. PubMed ID: 11314766
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Use of simultaneous double-tracer SPECT with 99m-Tc-technetril and 67-Ga-citrate for follow-up of patients with non-small cell lung cancer].
    Kanaev SV; Novikov SN; Beĭnusov DS; Girtovich MM; Levchenko EV; Barchuk AS; Semënov II; Zhukova LA; Matsko DE
    Vopr Onkol; 2012; 58(3):346-51. PubMed ID: 22888649
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [False-positive findings of 67-gallium scintigraphy in staging/restaging of malignant lymphoma].
    Bihl H; Kimmig B
    Rofo; 1987 Feb; 146(2):172-7. PubMed ID: 3029830
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Can Positron Emission Tomography and Computed Tomography Be a Substitute for Bone Marrow Biopsy in Detection of Bone Marrow Involvement in Patients with Hodgkin's or Non-Hodgkin's Lymphoma?
    Çetin G; Çıkrıkçıoğlu MA; Özkan T; Karatoprak C; Ar MC; Eşkazan AE; Ayer M; Cerit A; Gözübenli K; Uysal BB; Erdem S; Ergül N; Tatar G; Çermik TF
    Turk J Haematol; 2015 Sep; 32(3):213-9. PubMed ID: 25912844
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Non-Hodgkin lymphoma and Hodgkin disease: coregistered FDG PET and CT at staging and restaging--do we need contrast-enhanced CT?
    Schaefer NG; Hany TF; Taverna C; Seifert B; Stumpe KD; von Schulthess GK; Goerres GW
    Radiology; 2004 Sep; 232(3):823-9. PubMed ID: 15273335
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Fluorine-18 fluorodeoxyglucose PET/CT patterns of extranodal involvement in patients with Non-Hodgkin lymphoma and Hodgkin's disease.
    Even-Sapir E; Lievshitz G; Perry C; Herishanu Y; Lerman H; Metser U
    Radiol Clin North Am; 2007 Jul; 45(4):697-709, vii. PubMed ID: 17706534
    [TBL] [Abstract][Full Text] [Related]  

  • 27. 67Ga-SPECT/CT with a hybrid system in the clinical management of lymphoma.
    Palumbo B; Sivolella S; Palumbo I; Liberati AM; Palumbo R
    Eur J Nucl Med Mol Imaging; 2005 Sep; 32(9):1011-7. PubMed ID: 15895228
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Comparison of 18F-FDG coincidence SPECT imaging and computed tomography in the initial staging and therapeutic evaluation of lymphomas].
    Qiao WL; Zhao JH; Wang C; He ZY; Wang TS; Xing Y
    Zhonghua Zhong Liu Za Zhi; 2007 Jul; 29(7):536-9. PubMed ID: 18069637
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Three cases demonstrating the role of gallium scanning in relapsing Hodgkin's disease and non-Hodgkin lymphoma.
    Zollars LE; Nagel JS; Tumeh SS
    J Nucl Med; 1987 Oct; 28(10):1611-5. PubMed ID: 3655913
    [TBL] [Abstract][Full Text] [Related]  

  • 30. 67Ga scintigraphy for the evaluation of recurrences and residual masses in patients with lymphoma.
    Setoain FJ; Pons F; Herranz R; Vidal-Sicart S; Lomeña F; Ayuso C; Montserrat E; Setoain J
    Nucl Med Commun; 1997 May; 18(5):405-11. PubMed ID: 9194081
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Clinical value of FDG PET using coincident gamma cameras in staging and restaging of malignant lymphoma--compared with convenitonal diagnostic methods].
    Pichler R; Maschek W; Hatzl-Griesenhofer M; Huber H; Wimmer G; Wahl G; Fridrik M
    Nuklearmedizin; 2000 Sep; 39(6):166-73. PubMed ID: 11057408
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Aggressive non-Hodgkin lymphoma: early prediction of outcome with 67Ga scintigraphy.
    Front D; Bar-Shalom R; Mor M; Haim N; Epelbaum R; Frenkel A; Gaitini D; Kolodny GM; Israel O
    Radiology; 2000 Jan; 214(1):253-7. PubMed ID: 10644133
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Revisiting the prognostic role of gallium scintigraphy in low-grade non-Hodgkin's lymphoma.
    Gallamini A; Biggi A; Fruttero A; Pugno F; Cavallero G; Pregno P; Grasso M; Farinelli C; Leone A; Gallo E
    Eur J Nucl Med; 1997 Dec; 24(12):1499-506. PubMed ID: 9391185
    [TBL] [Abstract][Full Text] [Related]  

  • 34. 18F-fluorodeoxyglucose-positron emission tomography in the staging of malignant lymphoma compared with CT and 67Ga scan.
    Hong SP; Hahn JS; Lee JD; Bae SW; Youn MJ
    Yonsei Med J; 2003 Oct; 44(5):779-86. PubMed ID: 14584092
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Tc-99m sestamibi imaging in the diagnostic assessment of patients with lymphomas: comparison with clinical and radiological evaluation.
    Maurea S; Acampa W; Varrella P; De Rosa V; Fimiani P; Abate G; Salvatore M
    Clin Nucl Med; 1998 May; 23(5):283-90. PubMed ID: 9596152
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Agreement rates among single photon emission computed tomography using gallium-67, computed axial tomography and lymphangiography for Hodgkin disease and correlation of image findings with clinical outcome.
    Ha CS; Choe JG; Kong JS; Allen PK; Oh YK; Cox JD; Edmund E
    Cancer; 2000 Sep; 89(6):1371-9. PubMed ID: 11002233
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparison of technetium-99m methoxyisobutylisonitrile and gallium-67 citrate scanning in the assessment of lymphomas.
    Ziegels P; Nocaudie M; Huglo D; Deveaux M; Detourmignies L; Wattel E; Marchandise X
    Eur J Nucl Med; 1995 Feb; 22(2):126-31. PubMed ID: 7758499
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Lymphoma: role of whole-body 2-deoxy-2-[F-18]fluoro-D-glucose (FDG) PET in nodal staging.
    Moog F; Bangerter M; Diederichs CG; Guhlmann A; Kotzerke J; Merkle E; Kolokythas O; Herrmann F; Reske SN
    Radiology; 1997 Jun; 203(3):795-800. PubMed ID: 9169707
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Comparison of findings with 18-FDG PET and CT in pretherapeutic staging of malignant lymphoma].
    Thill R; Neuerburg J; Fabry U; Cremerius U; Wagenknecht G; Hellwig D; Osieka R; Günther R; Büll U
    Nuklearmedizin; 1997 Oct; 36(7):234-9. PubMed ID: 9441282
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Staging in childhood lymphoma: differences between FDG-PET and CT.
    Hermann S; Wormanns D; Pixberg M; Hunold A; Heindel W; Jürgens H; Schober O; Franzius C
    Nuklearmedizin; 2005 Feb; 44(1):1-7. PubMed ID: 15711722
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.